PEDIATRIC THROMBOSIS: A RETROSPECTIVE ANALYSIS OF THE INCIDENCE, CHARACTERISTICS AND RISK FACTORS IN A SPANISH CENTER.
EHA Library, Irene Sánchez Bazán, 294205
OUTCOME OF CHILDREN WITH PORTAL VENOUS THROMBOSIS
EHA Library, Selin Aytac, 294206
TROMBOFILIA STUDY IN PROVOCATED TROMBOEMBOLIC DISEASE
EHA Library, Bianca Díaz Roldán, 294207
IMPACT OF DEPTH OF RESPONSE AND MINIMAL RESIDUAL DISEASE ON HEALTH-RELATED QUALITY OF LIFE OF TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA
EHA Library, Maria Cristina Penaloza-Ramos, 294208
SURVIVORSHIP IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP) – IMPACTS ON QUALITY OF LIFE (QOL) AND COGNITIVE FUNCTIONING IN PATIENTS FROM THE UK
EHA Library, Steve Holmes, 294209
CML PATIENTS' VIEWS ON PSYCHOLOGICAL SUPPORT THROUGHOUT THE TREATMENT-FREE REMISSION JOURNEY
EHA Library, Giora Sharf, 294210
COST EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL (AXI-CEL) AND TISAGENLECLEUCEL (TISA-CEL) FOR ADULT PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA (RR LBCL) IN THE US
EHA Library, Julia Thornton Snide, 294211
MDS PATIENTS' NEEDS FROM ONLINE DISCUSSION FORUMS: AN ARTIFICIAL INTELLIGENCE AND NATURAL LANGUAGE PROCESSING ANALYSIS OF 20,000 POSTS IN US, UK, CANADA AND CHINA
EHA Library, Pauline Frank, 294212
HEALTHCARE RESOURCE USE AND TOTAL COST OF CARE AMONG PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES: AN ADMINISTRATIVE CLAIMS ANALYSIS
EHA Library, Ronda Copher, 294213
COST-EFFECTIVENESS OF GEMTUZUMAB OZOGAMICIN IN COMBINATION WITH STANDARD OF CARE CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF PATIENTS WITH CD33-POSITIVE ACUTE MYELOID LEUKEMIA IN SPAIN
EHA Library, Julia Llinares, 294214
A CROSS-SECTIONAL STUDY OF UNMET NEEDS OF LYMPHOMA PATIENTS IN PATIENT-DOCTOR COMMUNICATION
EHA Library, Lorna Warwick, 294215
ROLE OF FUNCTIONAL PARAMETERS IN ELDERLY AML PATIENTS DEEMED UNFIT FOR INDUCTION CHEMOTHERAPY: RESULTS FROM THE DECIDER TRIAL
EHA Library, Valerie Hupfer, 294216
PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN DUO: A RANDOMIZED TRIAL OF DUVELISIB VS. OFATUMUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
EHA Library, Pier Luigi Zinzani, 294217
SOCIAL FRAILTY PREDICTS WORSE OUTCOMES IN PHYSICALLY FRAIL PATIENTS WITH MULTIPLE MYELOMA DEFINED BY THE INTERNATIONAL MYELOMA WORKING GROUP FRAILTY SCORE
EHA Library, Toshiki Terao, 294218
TRANSFUSION BURDEN ON OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING LOW-INTENSITY TREATMENTS
EHA Library, Thomas Leblanc, 294219
HEALTHCARE RESOURCE UTILIZATION (HRU) IN THE RANDOMIZED, PLACEBO-CONTROLLED, PHASE III JAKARTA STUDY OF FEDRATINIB (FEDR) IN PATIENTS WITH INTERMEDIATE- OR HIGH-RISK MYELOFIBROSIS (MF)
EHA Library, Ruben Mesa, 294220
INCREASED MORTALITY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH PROTON PUMP INHIBITORS: A NATIONWIDE COHORT STUDY
EHA Library, Adam Vilmar, 294221
CLINICAL RELEVANCE OF GERIATRIC ASSESSMENT IN OLDER PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES – A SYSTEMATIC REVIEW
EHA Library, Reinhard Stauder, 294222
LIVING WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A QUANTITATIVE CROSS-SECTIONAL STUDY OF ITALIAN PATIENTS' EXPERIENCES ON BEHALF OF AIL (ASSOCIAZIONE ITALIANA CONTRO LE LEUCEMIE-LINFOMI E MIELOMI)
EHA Library, Stefano Molica, 294223
CLINICAL PROFILE AND OUTCOME OF CHILDREN WITH FEBRILE NEUTROPENIA TREATED ON AN AMBULATORY BASIS
EHA Library, Ramesh Natarajan, 294224
REAL WORLD ASSESSMENT OF HEALTH CARE RESOURCE USE ASSOCIATED WITH DLBCL TREATMENT PATTERNS IN JAPAN USING A NATIONWIDE RETROSPECTIVE CLAIMS DATABASE
EHA Library, Saaya Tsutsué, 294225
DREAMM-2: BELANTAMAB MAFODOTIN EFFECT ON DISEASE SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
EHA Library, Rakesh Popat, 294226
RENAL IMPAIRMENT INFLUENCES THE OUTCOME OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES : REAL-WORLD ANALYSIS OF 766 MOROCCAN PATIENTS
EHA Library, Mahtat EL MEHDI, 294227
PRAGMATIC APPROACH TO EMPOWERING PATIENTS WITH SCD: TOP 10 RESEARCH PRIORITIES FROM THE EUROPEAN EUROBLOODNET/ASCAT NETWORK OF SCD PATIENTS
EHA Library, Noemi Roy, 294228
STRUCTURED AFTERCARE CONSULTATION IN LYMPHOMA SURVIVORS REVEALS CHALLENGES, GOALS AND PLANNED INTERVENTIONS AFTER CHEMOTHERAPY
EHA Library, Kon-Siong Jie, 294229
EUROQOL-5D IS A VALID PATIENT-REPORTED OUTCOME MEASUREMENT (PROM) TOOL TO DISCRIMINATE HEALTH-RELATED QUALITY OF LIFE (HRQOL) IMPAIRMENTS AMONG YOUNGER AND OLDER PATIENTS WITH LYMPHOMA
EHA Library, Carola Lucía Diaz Aizpún, 294230
MULTIPLE MYELOMA IN PORTUGAL: BURDEN OF DISEASE AND COST OF ILLNESS
EHA Library, Manuel Neves, 294231
COMPARISON OF SAFETY MANAGEMENT COSTS ACROSS CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPIES IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA
EHA Library, Fei Fei Liu, 294232
ENROL: THE EUROPEAN RARE BLOOD DISORDERS PLATFORM
EHA Library, Victoria Gutierrez Valle, 294233
USEFULNESS OF ADMINISTRATIVE DATABASES TO IDENTIFY PATIENTS WITH HEMATOLOGIC MALIGNANCIES: THE 'PRIHTA - EMATOLOGIA' PROJECT
EHA Library, Luca Degli Esposti, 294234
IMPACT OF STEM-CELL TRANSPLANTATION ON HEALTHCARE UTILIZATION IN ACUTE MYELOID LEUKEMIA
EHA Library, Abhishek Maiti, 294235
RECENT TREATMENT PATTERNS, HEALTHCARE UTILIZATION, AND COSTS IN HEAVILY PRETREATED RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA PATIENTS IN THE UNITED STATES
EHA Library, Ajai Chari, 294236
HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH UNTREATED HIGHER-RISK MYELODYSPLASTIC SYNDROMES, ACUTE MYELOID LEUKEMIA, AND CHRONIC MYELOMONOCYTIC LEUKEMIA RECEIVING GLASDEGIB + AZACITIDINE.
EHA Library, Eunice Wang, 294237
QUALITATIVE ANALYSIS OF PRIOR KNOWLEDGE, CONCERNS, AND EXPECTATIONS OF PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA ENROLLED IN 2 TRIALS OF LISOCABTAGENE MARALEUCEL (LISO-CEL)
EHA Library, Julia Braverman, 294238
HEALTH-RELATED QUALITY OF LIFE ASSESSMENT AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING CHILDHOOD OR ADOLESCENCE
EHA Library, Rym El Fatmi, 294239
EXERCISE IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA – A RANDOMIZED, CONTROLLED TRIAL OF EFFECTS ON PHYSICAL FUNCTION, PHYSICAL ACTIVITY, PAIN AND QUALITY OF LIFE
EHA Library, Rikke Faebo Larsen, 294240
THE VALUE OF IMPROVED SURVIVAL IN ACUTE MYELOID LEUKAEMIA: UNDERSTANDING HOW PHYSICIANS, PATIENTS, AND THEIR FAMILY MEMBERS DEFINE QUALITY OF LIFE
EHA Library, Nigel Russell, 294241
DETERMINANTS OF QUALITY OF LIFE IN MULTIPLE MYELOMA PATIENTS: CROATIAN EXPERIENCE
EHA Library, Vibor Milunović, 294242
AXICABTAGENE CILOLEUCEL FOR THE MANAGEMENT OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AND PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: AN ECONOMIC EVALUATION FOR SPAIN
EHA Library, Maria Presa, 294243
PREDICTIVE FACTORS OF CARDIOTOXICITY IN LYMPHOMA PATIENTS RECEIVING ANTHRACICLINES IN THE FIRST LINE TREATMENT
EHA Library, Alberto López García, 294244
COMPARISON OF DIFFERENT GERIATRIC SCREENING METHODS IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKIN LYMPHOMA IN PERU
EHA Library, Brady Beltrán, 294245
IDENTIFYING FACTORS ASSOCIATED WITH VARIATIONS IN QUALITY OF LIFE FOR PATIENTS WITH DIFFERENT ACUTE LEUKEMIA TYPES: A GLOBAL SURVEY
EHA Library, Zack Pemberton-Whiteley, 294246
ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN SUPPORTIVE CARE OF LOW-RISK MYELODYSPLASTIC SYNDROMES
EHA Library, Claudio Cerchione, 294247
FACTORS ASSOCIATED WITH HYPOMETHYLATING AGENTS USE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR-MDS)
EHA Library, Amer Zeidan, 294248
SELECTION OF A SET OF QUALITY INDICATORS (QIS) ON THE CARE PATHWAY IN ONCO-HEMATOLOGY USING A PANEL OF EXPERTS
EHA Library, Jean-Henri Bourhis, 294249
AUDIT OF 86 PATIENTS REFERRED TO HAEMATOLOGY ON THE NHS 2-WEEK CANCER PATHWAY ON NHS E-REFERRALS
EHA Library, Sven Armin Sommerfeld, 294250
CENTRAL VENOUS CATHETERS AND ASSOCIATED COMPLICATION IN HEMATOLOGY MALIGNANCIES PATIENTS
EHA Library, Nikolay Romanenko, 294251
DEVELOPMENT OF A MOBILE APPLICATION FOR CLINICAL DECISION SUPPORT IN ACUTE LEUKEMIA
EHA Library, Jeff Schriber, 294252
A PHILOSOPHICAL APPRAISAL OF CLONAL EVOLUTION: UNLOCKING CONCEPTUAL BARRIERS TO THE TRANSITION FROM BENCH TO BEDSIDE
EHA Library, Lucie Laplane, 294253
MIR-130B AND MIR-128A ARE ESSENTIAL LINEAGE-SPECIFIC CO-DRIVERS OF T(4;11) MLL-AF4 ACUTE LEUKEMIA
EHA Library, Camille Malouf, 294254
MODELLING CHEMOTHERAPY RESPONSE IN XENOGRAFT MODELS OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Julie Morscio, 294255
INTERROGATION OF NICHE-RELATED DRUG RESISTANCE IN PH-LIKE ALL BY SINGLE CELL ANALYSIS
EHA Library, Ayan Saha, 294256
ATP-CITRATE LYASE (ACLY) PLAYS CRUCIAL ROLES IN ACUTE LYMPHOBLASTIC T-CELL LEUKAEMIA DEVELOPMENT
EHA Library, Melania Tesio, 294257
MYB ACTIVATION SYNERGIZES WITH PTEN LOSS TO FORM AGGRESSIVE T-ALL
EHA Library, André De Almeida, 294258
THE VALUE OF WHOLE TRANSCRIPTOME SEQUENCING FOR THE DETECTION OF RECURRENT AND NOVEL FUSION TRANSCRIPTS, COPY NUMBER ABERRATIONS AND SMALL NUCLEOTIDE VARIANTS IN ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Claudia Haferlach, 294259
DEFINITION AND PROGNOSTIC IMPACT OF PH-LIKE AND IKZF1-PLUS FEATURES IN CHILDREN WITH DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Chiara Palmi, 294260
ATAC-SEQ IDENTIFIES A HIGHLY ACCESSIBLE IMMATURE CHROMATIN PROFILE IN PEDIATRIC T-ALL DIVERGING FROM THAT OF HUMAN T-CELL PRECURSORS
EHA Library, Büşra Erarslan-Uysal, 294261
CREBBP VARIANTS CAN PREDISPOSE TO CHILDHOOD LEUKEMIA INDEPENDENTLY OF A SYNDROMAL RUBINSTEIN-TAYBI PHENOTYPE
EHA Library, Franziska Auer, 294262
IDENTIFYING THE NOVEL MECHANISMS WHICH DRIVE ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) AND ITS TREATMENT RESISTANCE TO IMPROVE CHILDHOOD ALL MORBIDITIES AND MORTALITY
EHA Library, Lynsey McKenzie, 294263
MICRORNA-497~195 CLUSTER SUPPRESSES ACUTE LYMPHOBLASTIC LEUKEMIA GROWTH BY TARGETING CCND3/CDK4 AND INHIBITING CELL CYCLE PROGRESSION
EHA Library, Elena Boldrin, 294264
MICRORNAS MEDIATING THE PARADOXICAL BENEFICIAL EFFECT OF RUXOLITINIB ON LEUKEMIC B-CELL PRECURSORS WITH MUTATIONAL ACTIVATION OF JAK2
EHA Library, Katarina Mekin, 294265
MUTATIONAL LANDSCAPE OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND SUBCLONAL EVOLUTION DURING CHEMOTHERAPY TREATMENT
EHA Library, Llucia Albertí Servera, 294266
ALTERED TF ACTIVITY AND CONTROL OF GENE EXPRESSION NOISE CHARACTERIZES THE LEUKEMIC CELL STATE IN ETV6-RUNX1-POSITIVE PEDIATRIC LEUKEMIA
EHA Library, Juha Mehtonen, 294267
WEE1 KINASE IS A THERAPEUTIC TARGET IN MLL ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH REGULATION OF RUNX1
EHA Library, Mari Lahnalampi, 294268
CASEIN KINASE II INHIBITION SENSITIZES ACUTE LYMPHOBLASTIC LEUKEMIA CELLS TO VENETOCLAX VIA MCL-1 DEGRADATION
EHA Library, Juan Lazaro, 294269
EZH2 AND CUX1 DELETIONS COOPERATE TO INDUCE EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A CONDITIONAL KNOCKOUT MOUSE MODEL
EHA Library, Saskia S. Rudat, 294270
A COMPREHENSIVE PIPELINE FOR SMALL-TO-MEDIUM SIZE, CRISPR/CAS9-BASED FUNCTIONAL GENETICS SCREENS WHICH CAN BE APPLIED TO PATIENTS' LEUKEMIA CELLS GROWING IN MICE
EHA Library, Diana Amend, 294271
THE MYB-TYK2 GENE FUSION INDUCES B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA IN IN VITRO AND IN VIVO MODELS AND CAN BE EFFECTIVELY TARGETED BY THE DUAL SYK/JAK INHIBITOR, CERDULATINIB.
EHA Library, Paniz Tavakoli, 294272
IDENTIFICATION OF CHEMOTHERAPY-RESISTANT SUBCLONES IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA USING CELLULAR BARCODES
EHA Library, Mirjam Belderbos, 294273
A RECURRENT GERMLINE PAX5 MUTATION PREDISPOSES TO FAMILIAL B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN ADOLESCENTS AND YOUNG ADULTS
EHA Library, Laura Jamrog, 294275
AURORA KINASES AS CANDIDATE EPIGENETIC TARGETS FOR T-ALL THERAPY
EHA Library, Cristina Prieto, 294276
UNEXPECTED HIGH RATE OF KNOWN AND UNKNOWN REARRANGEMENTS IN ADULT TRIPLE NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IDENTIFIED THANKS TO A EFFICIENT TRANSCRIPTOME FOUR TOOL PIPELINE ANALYSYS
EHA Library, Anna Ferrari, 294277
EX VIVO DRUG TESTING HIGHLIGHTS APOPTOSIS PATHWAYS AS TARGETS IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Helena Hohtari, 294278
MLL/AF4 PLAYS AN ESSENTIAL ROLE FOR ESTABLISHED ALL PDX TUMORS DURING THEIR GROWTH IN VIVO AS DETECTED BY INDUCIBLE KNOCKDOWN IN MICE
EHA Library, Kerstin Völse, 294279
CHARACTERIZATION OF MECHANISMS OF ACQUIRED VENETOCLAX-INSENSITIVITY IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Alexandra Niedermayer, 294281
SUBCLONAL TP53 MUTATIONS IN PEDIATRIC T-ALL AT INITIAL DIAGNOSIS MAY INDICATE AN INCREASED RISK FOR RELAPSE
EHA Library, Tamara Kempter, 294282
SIGNIFICANCE OF THE RECIPROCAL AF4-MLL FUSION PROTEIN IN T(4;11) ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Alexander Wilhelm, 294283
TP53 GERMLINE MUTATIONS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND THEIR RELATIONSHIP WITH LI-FRAUMENI SYNDROME
EHA Library, Ksenija Zarubina, 294284
LEDGF/P75 REGULATES CHEMORESISTANCE IN MIXED-LINEAGE LEUKEMIA.
EHA Library, Siska Van Belle, 294285
LNCRNA CRNDE KNOCKDOWN SUPPRESSES CELL PROLIFERATION AND PROMOTES CELL APOPTOSIS THROUGH MIR-345 IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Weimin Wang, 294286
ACTIVINA EFFECT ON ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL VESICULATION
EHA Library, Giulia Cricrì, 294287
NEXT GENERATION CYTOGENETICS: COMPREHENSIVE ASSESSMENT OF 48 LEUKEMIA GENOMES BY GENOME IMAGING
EHA Library, Marian Stevens-Kroef, 294288
ONE-STEP APPROACH FOR THE CLINICAL STRATIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS BY A CUSTOM NGS PANEL
EHA Library, Adrián Montaño, 294289
DUAL ROLE OF PSIP1/LEDGF IN T-ALL
EHA Library, Lisa DEMOEN, 294290
PARD3 EXPRESSION PROMOTES PROLIFERATION AND SURVIVAL OF LEUKEMIA CELLS AND CORRELATES WITH RELAPSE IN ADULTS WITH COMMON B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Yan Xu, 294291
PROGNOSTIC SIGNIFICANCE OF IKZF1 ALTERATIONS IN ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. POTENTIAL OF HARMONY ALLIANCE BIG DATA ANALYSIS FOR PRECISON MEDICINE
EHA Library, Jordi Ribera, 294292
CLINICAL, GENOMIC AND TRANSCRIPTOMIC FEATURES OF ADULT PHILADELPHIA-CHROMOSOME POSITIVE ACUTE LEUKEMIA
EHA Library, Wenzhi Cai, 294293
EVOLUTION OF TREATMENT RESISTANCE IN A PATIENT-DERIVED XENOGRAFT MOUSE MODEL OF ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Anna-Katharina Wirth, 294294
CORRELATION BETWEEN CD3+ T-CELLS IN CSF SAMPLES OF BLINATUMOMAB TREATED B ACUTE LYMPHOBLASTIC LEUKEMIA PEDIATRIC PATIENTS AND NEUROLOGICAL TOXICITY
EHA Library, Valentina Bertaina, 294295
ALTERATIONS OF FLT3 GENE IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CHARACTERISTICS AND OUTCOME IN PDT-ALL-2016
EHA Library, Dainan Lin, 294296
CAPTURE-BASED NGS PANEL FOR DETECTION OF IMMUNOGLOBULIN AND T-CELL RECEPTOR GENE REARRANGEMENTS IN DNA SAMPLES FROM PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Hana Jelínková, 294297
TEACHING AN OLD DOG NEW TRICKS: ACTIVITY-ON-TARGET INTERFERON TO TREAT T-ALL
EHA Library, Steven Goossens, 294299
PHARMACOGENETIC STUDY OF THE CENTRAL NERVOUS SYSTEM IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Judit C. Sagi, 294300
MICRORNA EXPRESSION PROFILING AS AN INSTRUMENT IN IDENTIFICATION OF ACUTE LEUKEMIAS
EHA Library, Y.A. Veryaskina, 294302
TREATMENT WITH BLINATUMOMAB OF PAEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA TREATED IN A REAL-WORLD SETTING: RESULTS FROM THE NEUF STUDY
EHA Library, Naufil Alam, 294303
MINIMAL RESIDUAL DISEASE, CLINICAL OUTCOME, AND THE EFFECT OF IKZF1 DELETIONS IN PEDIATRIC DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKEMIA: AN INTERNATIONAL MATCHED PONTE DI LEGNO CASE-CONTROL STUDY
EHA Library, Naomi Michels, 294304
INOTUZUMAB OZOGAMYCIN IN RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS IN 56 PATIENTS TREATED IN GRAALL CENTERS
EHA Library, Sylvain Chantepie, 294305
SEQUENCING OF NOVEL AGENTS IN B-CELL ACUTE LYMPHOCYTIC LEUKEMIA (ALL): BLINATUMOMAB AND INOTUZUMAB OZOGAMICIN HAVE COMPARABLE EFFICACY AS FIRST OR SECOND NOVEL AGENT THERAPY IN ALL
EHA Library, Talha Badar, 294307
NGS-BASED MRD QUANTITATION PROVIDES USEFUL CLINICAL INFORMATION FOR THE RISK STRATIFICATION OF CHILDHOOD ALL TREATED WITH MRD-BASED PROTOCOL
EHA Library, Aneta Skotnicova *, 294308
SPECTRUM AND CLINICAL CHARACTERISTICS RELEVANCE OF GENE MUTATIONS IN CHINESE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Yongmin Tang, 294309

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings